Introduction
Hox proteins constitute a family of transcription factors which control gene expression networks that regulate biological processes such as neurogenesis, patterning, organogenesis and cancer (Alexander et al., 2009; Capecchi, 1997) . Mouse knockout studies revealed that Hox genes execute their role in a specific segment or domain of the embryo, often affecting several tissues at a given axial level (Mallo et al., 2010) . Although many gain-and loss-of-function experiments have been carried out, little is known about the molecular targets and the developmental pathways regulated by Hox genes (Hueber and Lohmann, 2008) . In this study, we set out to identify the downstream targets of a specific Hox gene, Hoxa1. This gene affects the development of a diverse array of tissues in the anterior domain of the embryo including the brainstem, inner ear and heart.
Hoxa1 is strongly expressed in the neuroectoderm and mesoderm at the level of the presumptive hindbrain (precursor of the brainstem) from mouse embryonic day (E) 7.75 to 8.5 (Murphy and Hill, 1991) . Hoxa1 knockout mice die at or shortly after birth from breathing defects, which are thought to result from mispatterning of the hindbrain (Chisaka et al., 1992; Lufkin et al., 1991) . During development, the hindbrain is subdivided into eight transient territories termed rhombomeres (r) (Lumsden and Krumlauf, 1996) and Hoxa1 −/− embryos exhibit abnormalities in r3-r5. Additionally, the otic vesicle (embryonic progenitor of the inner ear) forms but fails to differentiate and cranial ganglia, condensations of sensory neurons in the head, are smaller and do not connect properly with the brain (Mark et al., 1993) . Cranial ganglia develop in part from cranial neural crest cells, which migrate from the dorsal hindbrain (Barlow, 2002) , where Hoxa1 is expressed. So far it is unclear through which mechanisms Hoxa1 regulates the development of neural crest cells or the inner ear. Hoxa1 lineage analysis suggests that Hoxa1 might play a direct role in early patterning of the otic placode (precursor of the otic vesicle) and specification of neural crest cell precursors, while they reside in the neural tube (Makki and Capecchi, 2010) .
More recently, humans with homozygous truncating mutations in HOXA1 have been identified (Athabascan Brainstem Dysgenesis Syndrome and Bosley-Salih-Alorainy Syndrome). These patients suffer from hypoventilation (requiring mechanical ventilation), deafness, facial weakness, vocal cord paralysis and swallowing dysfunction (Holve et al., 2003; Tischfield et al., 2005) . In addition, patients display defects in the outflow tract of the heart, which have not been described in mice so far. Notably, the development of the cardiac outflow tract depends on the influx of neural crest cells, which originate in the posterior hindbrain at the level of r6-r8 (Brown and Baldwin, 2006) , where Hoxa1 is expressed.
Despite of what we know about the importance of Hoxa1 in proper development of several embryonic tissues in humans and mice, almost nothing is known about the transcriptional network that is regulated by this protein. In this study, we carried out a genome-wide microarray analysis to identify genes that are differentially expressed between control and Hoxa1 null embryos. For genomic profiling, tissue was microdissected from the prospective rhombomere 3-5 region of Hoxa1 Δ/Δ and wild type embryos at the 1-6 somite stage (ss). Our analysis identified novel targets of Hoxa1 that play a role in neural crest specification, otic placode patterning, and reticulospinal neuron development.
Materials and methods

Gene targeting and genotyping
A 7.9 kb genomic DNA fragment containing the Hoxa1 locus was subcloned into a conventional plasmid and an artificial AscI site was placed 36 bp downstream of the stop codon as described previously (Tvrdik and Capecchi, 2006) . To generate the Hoxa1 conditional allele (Hoxa1 c ), one loxP site together with an EcoRI site were inserted 200 bp upstream of the Hoxa1 transcription initiation site into a SwaI site. The downstream loxP site along with an EcoRI site and a PolII-frtNeo-frt selection cassette were inserted into the artificial AscI site 3′ of the Hoxa1 stop codon. Positive clones were identified by digesting genomic DNA with EcoRI, Southern blotting and hybridization with a 5′ external probe. Selected clones were further analyzed by digestion with KpnI and hybridization with an exon1 and a Neo probe. Positive ES cell clones were injected into C57BL/6 blastocysts and chimeric males were crossed to C57BL/6 females. The neomycin resistance gene was removed by crossing the mice to anFlpe-deleter line (Rodriguez et al., 2000) . The Hoxa1-deletion allele (Hoxa1 Δ ) was generated by crossing Hoxa1 conditional mice to an Hprt-Cre deleter mouse (Tang et al., 2002) . Recombination was verified by Southern analysis and PCR. Genotyping was performed using multiplex PCR. The following primers were used: wild type forward NM228 5′-TGAGGCTACTC-CAGCCCAACTC-3′, deletion forward NM230 5′-CTCTCACCTCTTGC-CAGTTCAGC-3′, reverse NM229 5′-CAATTGATGTGGACACCCGATG-3′, generating a 220 bp wild type, a 326 bp conditional and a 520 bp deletion band.
Mouse breeding and tissue dissection
Hoxa1
Δ/+ mice were maintained on a C57BL/6 background. Timed matings were set up between Hoxa1 Δ/+ mice and embryos were harvested at E8.25. Deciduas were isolated in cold PBS and transferred into HEPES-buffered DMEM with 5% FBS on ice. Each embryo was isolated in a separate dish in PBS, extraembryonic tissues were removed and the number of somites counted. Using fine tungsten knives, the bulge region (rhombomere 3-5), including neuroectoderm, mesoderm and otic ectoderm, was isolated and the tissue trimmed by a horizontal cut at the level of the floorplate. The tissue was then transferred into 40 μl of RLT buffer (Qiagen Micro-RNA Easy kit), vortexed immediately for 1 min and stored on ice until all embryos were processed. The yolk sac was collected for DNA isolation and genotyping. Finally, the tissue was homogenized by vortexing for 5 min followed by snap freezing in liquid nitrogen and storage at −80°C. A total of 221 embryos were collected and sorted according to genotype (verified at least twice) and somite stage. Twenty-four wild type and 24 Hoxa1 Δ/Δ embryos at the 1-6 somite stage were chosen for analysis and pooled into four wild type and four mutant samples, containing one embryo of each somite stage.
RNA isolation, array hybridization and statistical analysis RNA was isolated from the eight samples using the RNAqueousMicro Kit (Ambion) with an on-column DNase treatment (Qiagen). The concentration and quality of the RNA was determined at the University of Utah Microarray Core Facility using a Nanodrop and Bioanalyzer (Agilent). The RNA Integrity Number (RIN) deduced from this analysis was 9.9-10 for all samples, which denotes an excellent RNA quality with no degradation (Schroeder et al., 2006) . The final concentrations of total RNA varied from 15 to 20 ng/μl and 150 ng of RNA from each pool was subjected to a single linear amplification labeling reaction with Cy3. RNA was hybridized to Agilent mouse whole genome 44 K microarray slides (Agilent), using the Agilent one-color gene expression hybridization protocol. Slides were scanned (Agilent G2505B) at 5 μm resolution using an extended dynamic range protocol, and images were processed with Agilent Feature Extraction software 10.5.1.1. Within-array normalization was performed using the "Background detrending" software (Agilent). The nonuniform outlier features (spots) were removed and the intensity values were transformed to a log base 2 scale. Signal density blots showed uniform ranges and distributions of intensity values from each array and no between-array normalization was necessary. All eight array files were then compiled into a working directory and imported into the statistical analysis program "R" (Dudoit et al., 2003) . Genes significantly differentially expressed were identified using the Rank Products algorithm with the default setting of 100 permutations (Breitling et al., 2004) . Rank Products analysis was chosen because of its biologically meaningful emphasis on the fold change of gene expression and the reproducibility in samples with small numbers of replicates. GO analysis was performed using DAVID (Dennis et al., 2003; Huang da et al., 2009 ) on significantly differentially expressed genes. In case of overlapping and similar GO terms, one representative is listed, and terms that are too general were not included. Data was hierarchically clustered with Spotfire (TIBCO) and heat maps for selected genes were generated. The microarray data can be found in the Gene Expression Omnibus (GEO) of NCBI through accession number GSE25868.
Quantitative real-time PCR (qPCR)
60 ng of total RNA was linearly amplified using the qScript cDNA SuperMix (Quanta Biosciences). Reverse transcription and PCR conditions were essentially as described (Schmittgen and Livak, 2008) using the SYBR Green detection method. Primer pairs (Table S2) were obtained from the PrimerBank database (Wang and Seed, 2003) . Reactions were run on a 7900HT thermal cycler (Applied Biosystems) in the Genomics Core Facility at the University of Utah. For the final experiment, three wild type and three Hoxa1 Δ/Δ cDNA samples (biological replicates) were analyzed individually in three replicates of each reaction (technical replicates) and the mean threshold cycle (C T ) for each gene was derived. Relative expression levels were calculated by the ΔC T method (Schmittgen and Livak, 2008) , normalizing to the housekeeping gene β-actin, and data expressed as mean fold change relative to wild type. Unpaired, two-tailed Student's t-test was used to calculate P values between the Hoxa1 null and control samples.
Inner ear paint-filling and RNA in situ hybridization
For inner ear paint-filling, E15.5 embryos were harvested and fixed overnight in Bodian's fixative. Embryos were washed in PBS, dehydrated in ethanol and cleared in methyl salicylate. Heads were hemisected and inner ears injected with 2% white latex paint in methyl salicylate using a micropipette (Morsli et al., 1998) . For RNA in situ hybridization, Digoxigenin-labeled antisense cRNA probes were generated from plasmids carrying cDNA fragments. The following cloned mouse cDNAs were obtained, sequenced and used to prepare riboprobes: Foxd3 (from T. Labosky) (Labosky and Kaestner, 1998) , Hnf1b and Lhx5 (from Q. Ma) (Gray et al., 2004) , Spry4 (from K. Shim/ G. Martin) (Minowada et al., 1999) , Pax8 (from A. Groves) (Ohyama and Groves, 2004) , Zic1 (from R. Arkell) (Elms et al., 2004) , Lefty2 (from Y. Saijoh/H. Hamada) (Meno et al., 1996) , Hnf4a (from Y. Saijoh). Probes for Fzd8 and Fgfr3 (from L. Urness) were generated following direct PCR amplification of the 3′ UTR from genomic DNA. A 28-base T7 RNA polymerase promoter (5′-GGATCCTAATACGACTCAC-TATAGGGAG-3′) was incorporated at the 5′ end of the reverse primer. Whole-mount in situ hybridization was performed on embryos isolated from timed pregnancies essentially as described (Henrique et al., 1995) .
Results
Hoxa1
Δ/Δ mice exhibit the same phenotypes as previously described
Hoxa1 null lines
A new Hoxa1 null allele (Hoxa1 Δ ) was created by flanking the Hoxa1 coding region with loxP sites to generate a conditional allele ( Fig. 1A ) and then deleting the intervening sequence using Cre recombinase. Hoxa1 conditional (Hoxa1 c ) mice were generated from targeted ES cells (Fig. 1B) and then crossed to a Flpe-deleter line (Rodriguez et al., 2000) to excise the neomycin resistance gene. Mice homozygous for the Hoxa1 conditional allele are phenotypically wild type. To generate a Hoxa1-deletion allele (Hoxa1 Δ ), Hoxa1 conditional mice were crossed to an Hprt-Cre deleter line (Tang et al., 2002) . As expected, mice with a homozygous deletion of Hoxa1 (Hoxa1 Δ/Δ ) resemble previously reported Hoxa1 null mice (Chisaka et al., 1992; Mark et al., 1993) . Hoxa1 Δ/Δ mice are born at normal Mendelian ratios but die shortly after birth at perinatal day P0-P1 (n = 34). We also examined Hoxa1 Δ/Δ embryos for inner ear defects using the inner ear paint-fill technique (Morsli et al., 1998) and found that the otic vesicle forms but does not differentiate (Figs. 1C, C′) (n = 7), as was reported in previous studies (Pasqualetti et al., 2001) . Therefore, the Hoxa1 Δ allele represents a new Hoxa1 null allele, which was used in all subsequent experiments.
Hoxa1 is expressed very transiently in its most anterior domain
Previous studies showed that Hoxa1 is most strongly expressed in the anterior hindbrain (prospective r3-r5) and neighboring mesoderm (Makki and Capecchi, 2010; Murphy and Hill, 1991) and that all phenotypes resulting from loss of Hoxa1 function are associated with its most anterior expression domain (Chisaka et al., 1992; Lufkin et al., 1991) . Therefore, we wanted to identify the exact embryonic time window, during which Hoxa1 is expressed in the prospective r3-r5 region by carrying out RNA in situ hybridization at specific somite stages. As reference we visualized Krox20 expression, which can be detected in r3 from the 4ss and in both r3 and r5 from the 7ss (Figs. 2A, B) (Mechta-Grigoriou et al., 2000) . Our analysis revealed that Hoxa1 is only expressed in its most anterior domain (the prospective r3/r4 boundary) from E7.75-2ss (data not shown). From the 2ss (~E8.0), Hoxa1 expression starts retracting to posterior r4. At the 4ss (~E8.25), when Krox20 is first expressed as a single stripe in r3, Hoxa1 has retracted to r5 ( Fig. 2A) . When the second stripe of Krox20 appears in r5 at the 7ss (~E8.5), Hoxa1 is no longer expressed in this rhombomere (Fig. 2B) . Thus, Hoxa1 is expressed for only around 12 h (E7.75-6ss) in its most anterior domain, which is much more transient than previously believed (Murphy and Hill, 1991) . 
Identifying and isolating the relevant tissue for microarray analysis
In order to identify genes regulated by Hoxa1, we set out to collect tissue from the prospective r3-r5 region of Hoxa1 Δ/Δ and wild type embryos for microarray analysis. Since our in situ experiments revealed that Hoxa1 is expressed in this region from around E7.75 to the 6ss, we chose to collect embryos at the 1-6ss. This is an approximately eight-hour time window (Tam, 1981) , around and slightly after the peak of Hoxa1 expression, and before phenotypic manifestations are apparent in Hoxa1 null embryos. Therefore, we believe that our experimental setup would allow identification of both direct and indirect targets of Hoxa1. Conveniently, at this time the prospective r3-r5 region is morphologically visible as a "bulge" that forms in the future hindbrain ( Fig. 2A , B open brackets). The bulge region was microdissected by performing two cuts along the edges of the bulge (Fig. 2C ) and then trimming the tissue at the level of the floorplate to include neuroectoderm, mesoderm and otic ectoderm at the level of r3-r5 (Fig. 2D ). To confirm that the bulge region included the entire r3-r5 region, we performed in situ hybridization for Krox20 after cutting the tissue (Fig. 2C ). Since Hoxa1 null mice also exhibit severe inner ear defects, we wanted to include the otic ectoderm, the precursor of the inner ear, which develops at the level of r4-r5 (Ohyama and Groves, 2004) . In situ staining for the otic marker Pax2 on cut tissue confirmed that this region was included in our dissection (Fig. 2C) . Finally, we wanted to verify that the tissue chosen for dissection would allow us to detect expression changes in known Hoxa1 downstream targets between wild type and Hoxa1 null embryos. Therefore, we isolated RNA from a small number of dissected embryos and performed RT-PCR on two of the few known Hoxa1 targets, Hoxb1 and Kreisler (Mafb) (Pasqualetti et al., 2001) . We saw clear changes in RNA levels of these two genes between the two genotypes ( Fig. 2E ). This gave us confidence to carry out a large scale analysis using this technique (Fig. 3A) . A total of 221 embryos from 52 Hoxa1 Δ/+ females were dissected and genotyped. The Mendelian ratio was as follows: 21% homozygous, 51% heterozygous and 28% wild type. For microarray analysis, embryos at the 1-6 somite stage were pooled into four wild type and four mutant samples, each containing one embryo per somite stage.
Microarray analysis reveals Hoxa1 candidate targets involved in different developmental processes
To enable a comprehensive assessment of Hoxa1-regulated genes we compared gene expression profiles of four Hoxa1 Δ/Δ and four wild type samples using genome-wide microarray analysis. Rank Products analysis (Breitling et al., 2004 ) yielded a list of 299 differentially expressed genes (137 down-regulated and 162 up-regulated in the mutant) with a ≥ 2-fold change in expression at a false discovery rate of 0.05 and with P-values≤ 0.0002 (Table S1 ). As expected, the most highly down-regulated gene in this list is Hoxa1, with a fold change of 70. The two known downstream targets of Hoxa1 were also among the downregulated genes in the list: Mafb (Kreisler) (Pasqualetti et al., 2001 ) and Hoxb1 (Barrow et al., 2000) , with a 6.7-fold (third most highly downregulated gene) and a 2.5-fold down-regulation, respectively. In order to identify other "genes of interest", we scanned the whole list of 299 potential targets for genes that fulfill one of two criteria: (i) known to play a role in a developmental process or (ii) expressed during early embryogenesis. Twelve of the 137 down-regulated and seven of the 162 up-regulated genes were selected as potentially interesting candidates (Table 1 ). The magnitude of expression changes of the selected genes in each of the four samples is illustrated in the intensity map representations (Fig. 3B) . In order to identify biological processes that might be regulated by Hoxa1, we carried out gene ontology (GO) analysis of significantly up-and down-regulated genes using the DAVID software (Database for Annotation, Visualization and Integrated Discovery) (Dennis et al., 2003; Huang da et al., 2009 ). This analysis identified categories such as hindbrain development, inner ear development, vascular development, neuron differentiation and cell migration (Fig. 3C) . Several of the genes listed under one of these categories were also selected as "genes of interest".
Validation of microarray targets by quantitative PCR
We carried out two qPCR experiments to identify and validate novel downstream targets of Hoxa1. First, we performed an initial qPCR screening of the 19 "genes of interest" ( somite embryos (the same samples used for microarray analysis). Unpaired, two-tailed Student's t-test was used to calculate P values between Hoxa1 null and control samples. In agreement with the microarray results, Lhx5 and Foxd3 were~5-fold down-regulated; Hnf1b, Pax8 and Zic1 were~2-fold down-regulated and Fgfr3 was~2-fold up-regulated compared to wild type (Fig. 4) .
Validation of microarray targets by in situ hybridization
To further validate candidates from our "gene of interest" list, we compared gene expression in somite-matched Hoxa1 null and control embryos by whole mount in situ hybridization. Expression patterns of the following genes were examined: Fgfr3, Foxd3, Fzd8, Hnf1b, Hnf4a, Lefty2, Lhx5, Pax8, Spry4, Zic1. No obvious differences in expression of Spy4, Fzd8 or Lefty2 were seen between Hoxa1 Δ/Δ and control embryos at the 3-10ss (data not shown) and Hnf4a was not detected in embryonic tissue prior to E8.5. Interesting differences were found in the expression patterns of Foxd3, Zic1 and Hnf1b, all genes known to be expressed in neural crest precursors in the hindbrain. Foxd3 expression in the hindbrain bulge region (prospective r4) was absent in Hoxa1 mutants and expression in the posterior hindbrain (prospective r6-r8) was reduced (Figs. 4A, A′) . Similarly, expression of Zic1 and Hnf1b in the posterior hindbrain (future r5-r8) of Hoxa1 mutants was severely reduced (Figs. 4B, C, B′, C′). Moreover, expression of Pax8, a gene required for otic placode specification, was reduced in the placode of Hoxa1 null embryos as early as the 4ss (Figs. 4D, D′) . Consistent with upregulation of Fgfr3 expression in the microarray and by qPCR, in situ analysis revealed an anterior expansion of Fgfr3 expression from the r4/r5 boundary in wild type embryos to the r3/r4 boundary in Hoxa1 null embryos (Figs. 4E, E′) . Finally, we detected Lhx5 expression in the hindbrain bulge region (prospective r4) as early as E8.25 (6 somite stage) (Fig. 4F ). This expression domain was absent in Hoxa1 mutants (Fig. 4F′) . Interestingly, three of the validated genes (Foxd3, Zic1, Hnf1b) are known to play a role in neural crest development (Aruga, 2004; Barbacci et al., 1999; Dottori et al., 2001) , two of the genes (Pax8, Fgfr3) are important for inner ear development (Mackereth et al., 2005; Pannier et al., 2009) (Table 1) .
Discussion
Although Hoxa1 is crucial for proper development of the hindbrain, inner ear and neural crest in humans and mice, little is known about the downstream genes that are controlled by this transcription factor. Here, we carried out microarray analysis of this early expressed Hox gene and compiled a list of 299 candidate targets. Through systematic analysis of this list, we validated an interesting set of Hoxa1 effector genes. These genes are known to control specific developmental processes such as neural crest induction, inner ear patterning and hindbrain neuron specification and can now be placed in a gene cascade downstream of Hoxa1. This allows us to suggest a new model for how Hoxa1 might regulate the development of the above tissues (Fig. 5) and opens up many new avenues for further investigation. To our knowledge, this is the first microarray analysis performed as early as E8.25 to identify gene expression patterns in the developing mammalian hindbrain and adjacent tissues.
Identification and validation of six novel downstream targets of Hoxa1 involved in development of the neural crest, inner ear and hindbrain neurons
From the list of 299 putative Hoxa1 targets, we selected 19 genes for further analysis. These genes were chosen based on their expression during early embryogenesis and/or a proposed function in a developmental process or signaling pathway. Of the 19 genes, six validated by qPCR and in situ hybridization. Three of the validated Hoxa1 targets, Foxd3, Zic1 and Hnf1b are involved in early neural crest development. Foxd3 is expressed in premigratory neural crest cells in the hindbrain at around E8.5 (Labosky and Kaestner, 1998) and has been shown to promote the development of neural crest from neural tube progenitors (Dottori et al., 2001) . Deletion of Foxd3 in neural crest cells using the Wnt1-Cre driver results in loss of neural crestderived structures (Teng et al., 2008) . In Foxd3 c/− ; Wnt1-Cre embryos cranial neural crest-derived ganglia and nerves are smaller. The same phenotype is seen in Hoxa1 null embryos, where cranial ganglia and their associated nerves are reduced in size (Mark et al., 1993) , suggesting that Hoxa1 acts upstream of Foxd3 in neural crest development. The second gene, Zic1, is expressed in the neural tube, including the dorsal hindbrain from which neural crest cells arise (Elms et Nineteen candidate genes were selected from the total list of 299 differentially expressed genes for further analysis by qPCR and/or in situ hybridization, based on their published expression pattern and/or proposed function during development as deduced from the Mouse Genome Informatics (MGI) webpage (http://www.informatics.jax.org/). Twelve candidates were selected from the list of down-regulated genes (top) and seven from the list of up-regulated genes (bottom). Genes highlighted in green or red were confirmed to be down-or up-regulated, respectively. FC, fold change.
was shown to play a role in early neural plate patterning, neural fate acquisition and neural crest specification in Xenopus (Aruga, 2004; Merzdorf, 2007) , where it acts upstream of Pax3 and interacts with Gbx2, the earliest factor in neural crest induction ).
Zic1
−/− mice exhibit cerebellar abnormalities but neural crest defects have not been studied in these mice. Besides Foxd3 and Zic1, which play a role in neural crest specification, we identified Hnf1b as a downstream target of Hoxa1. This gene is expressed in the hindbrain, neural crest cells and the foregut at E8.0 and is required for visceral endoderm specification and differentiation (Barbacci et al., 1999; Coffinier et al., 1999; Haumaitre et al., 2005) . Because of the role in visceral endoderm development, Hnf1b null mice die at E7.5 (Coffinier et al., 1999) and the role of Hnf1b in mammalian hindbrain and neural crest development has not been studied. Hnf1b is, however, known to play a role in hindbrain development in zebrafish (Choe et al., 2008) , where loss of Hnf1b function results in complete absence of Krox20 expression in r5. This is reminiscent of Hoxa1 knockout mice, where r5 is absent and the second stripe of Krox20 expression, which normally marks this rhombomere, is missing (Lufkin et al., 1991) . Analysis of cis-regulatory sequences governing Krox20 expression identified a conserved enhancer containing a binding site for the Hnf1b transcription factor, which is necessary for the initiation of Krox20 expression (Chomette et al., 2006) . Therefore, our findings suggest that Hoxa1 acts upstream of Hnf1b in the initiation of Krox20 expression in r5 (Fig. 5) . Interestingly, our in situ analysis revealed that Foxd3, Hnf1b and Zic1 are strongly reduced in the posterior hindbrain (r6-r8) of Hoxa1 null embryos. This region of the hindbrain is not mispatterned in Hoxa1 mutants and was thought to be unaffected by loss of Hoxa1 function. The posterior hindbrain gives rise to cardiac neural crest cells, which are important for remodeling of the cardiac outflow tract which is affected in humans with mutations in HoxA1. Therefore, reduction of Foxd3, Zic1 and Hnf1b, three neural crest markers, in the posterior hindbrain of Hoxa1 null mice suggests that Hoxa1 might play a direct role in cardiac neural crest development and that this could be the reason for the outflow tract defects in HoxA1-syndrome patients.
Two other confirmed genes, Pax8 and Fgfr3, are known to be important for inner ear development. Pax8 is expressed in the otic placode starting at the pre-somite stage (Ohyama and Groves, 2004) and plays a role in otic placode induction and specification (Mackereth et al., 2005) . It is interesting to find changes in Pax8 expression as early as the 4 somite stage, since gene expression profiles have not been analyzed in the otic placode of Hoxa1 mutants prior to E9.25 (~20 somite stage), when morphological changes have already occurred (Pasqualetti et al., 2001 ). This suggests that Hoxa1 affects inner ear development at a very early stage, presumably during otic placode specification and might, therefore, play a direct role in inner ear development. The only validated Hoxa1 downstream target that was up-regulated in Hoxa1 mutants was Fgfr3. Expression of Fgfr3 was found to be expanded in the hindbrain of Hoxa1 null embryos, extending from its normal border at the r5/r6 boundary anteriorly into r4. Fgf signaling in several tissues, including the hindbrain, is known to influence inner ear development (Zelarayan et al., 2007) and it was shown that activating Fgfr3 mutations can cause hearing loss and inner ear defects in humans and mice (Mansour et al., 2009 , Pannier et al., 2009 ). Since Hoxa1 is strongly expressed in r4, it is possible that it acts as an inhibitor of Fgfr3 in the hindbrain and that release of this inhibition leads to ectopic activation of Fgfr3, which might contribute to the inner ear defects in Hoxa1 null mice.
Finally, Lhx5 was identified as a novel downstream target of Hoxa1. Lhx5 expression in the hindbrain has previously been reported at E10.5 (Gray et al., 2004) . Our in situ and qPCR data now show that Lhx5 is already expressed as early as E8.25 (6 somite stage). Interestingly, Lhx5 has been implicated in the determination of reticulospinal neuron identity at E12.5 (Cepeda-Nieto et al., 2005) . These neurons are involved in modulation of respiration and cardiovascular function both of which are affected by loss of Hoxa1. It is, therefore, possible that Hoxa1 acts upstream of Lhx5 in the development of hindbrain reticulospinal neuron precursors.
In conclusion, we identified Hnf1b, Foxd3 and Zic1 as Hoxa1 downstream targets which are involved in hindbrain and early neural crest development. Interestingly, these markers were reduced in the posterior hindbrain, where cardiac neural crest cells originate suggesting that Hoxa1 might play a role in the development of these cells. Additionally, we identified changes in the expression patterns of Pax8 and Fgfr3, two genes important for inner ear development, which indicates that Hoxa1 affects otic placode specification. Whether it does so directly or through signaling from the hindbrain remains to be shown. Finally, Lhx5, a gene expressed in hindbrain reticulospinal neuron precursors, was down-regulated in Hoxa1 mutants raising the possibility that Hoxa1 acts upstream of Lhx5 in the development of these neurons (Fig. 5) . Although our experiments do not allow us to conclude if the identified six genes are direct or indirect targets of Hoxa1, they are likely to play important regulatory roles in the development of the tissues affected by loss of Hoxa1.
In addition to identifying effectors of Hoxa1 in neural crest, inner ear and hindbrain development, our array provides a long list of novel potential targets involved in other developmental and cellular processes such as cardiac and vascular development or neuron and muscle cell differentiation (Fig. 3C ), which will be the ground for future investigations.
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Hindbrain patterning Fig. 5 . Proposed model for the regulation of hindbrain, inner ear and neural crest development by Hoxa1. Our data suggests that Hoxa1 influences hindbrain patterning through Hnf1b, which in turn activates Krox20. It also suggests that Hoxa1 might regulate neural crest development, through Foxd3, Zic1 and Hnf1b, which could be the reason for the outflow tract defects in humans. In inner ear development, Hoxa1 acts upstream of Pax8 and Fgfr3. In addition, Hoxa1 might regulate Lhx5 expression in reticulospinal neuron precursors, which could contribute to the respiratory defects in Hoxa1 knockout mice. Whether the above effects are direct or through Hoxa1's influence on hindbrain patterning remains to be shown (as highlighted by the dotted arrows) and will be the ground for future investigations.
Comparison of Hoxa1 microarray results to other published microarray experiments
Ten microarrays have been published which identified Hox downstream targets in the mouse (reviewed by Hueber and Lohmann, 2008) . Of these, six have been carried out on mouse tissue that expresses the gene of interest, whereas the other four, including two Hoxa1 microarrays (Martinez-Ceballos et al., 2005; Shen et al., 2000) , have been performed on cultured cell lines. We compared the list of genes identified in our microarray with the lists of the two published Hoxa1 microarrays performed on cultured cells. None of the 28 putative downstream effectors identified in the differential hybridization screening of teratocarcinoma cells overexpressing Hoxa1 (Shen et al., 2000) were found in our microarray. In the second Hoxa1 microarray study, which compared gene expression profiles of wild type and Hoxa1 −/− embryonic stem cells treated with retinoic acid, 145 targets were identified (Martinez-Ceballos et al., 2005) . Only 45 of these targets are available online and again none of them were identified in our experiment. This is not surprising, since our microarray and the previously published ones constitute very different experiments. The two previous microarrays identified Hoxa1 targets in embryonic stem or cancer cells. Our study now adds a valuable new list of downstream targets, which are controlled by Hoxa1 in the developing embryo.
Microarrays were also performed on Hoxb1 (Tvrdik and Capecchi, 2006) , the paralog of Hoxa1 in mice and its ortholog hoxb1a in zebrafish (Rohrschneider et al., 2007) . Since Hoxa1 and Hoxb1 are paralogous members and may share some downstream targets, we compared our Hoxa1 dataset with the datasets from the above Hoxb1 studies. The following genes were differentially expressed in both our Hoxa1 microarray as well as either the mouse Hoxb1 or zebrafish hoxb1a microarray and might represent common targets of the two genes: Zinc finger protein of the cerebellum 1 (Zic1), delta/notch-like EGF-related receptor (Dner), nephronectin (Npnt), transthyretin (Ttr), Sjogren syndrome antigen B (Ssb), Nik related kinase (Nrk), DEAD box polypeptide 3 (Ddx3y), leucine rich repeat containing 4 (Lrrc4).
Since Hoxa1 is of profound importance to the development of a variety of tissues, analysis of some of the targets on our list allowed us to propose a model for how Hoxa1 might regulate specific aspects of hindbrain, inner ear and neural crest development. Further investigation into the molecular mechanisms through which Hoxa1 orchestrates the development of these tissues will be necessary to better understand the origin of the defects in HoxA1-syndrome patients. We believe that this study might provide a first stepping stone in this direction.
Supplementary materials related to this article can be found online at doi:10.1016/j.ydbio.2011.06.042.
